DHODH and arthritic joint disease: DUP785 (Brequinar) and leflunomide have been shown to be potent anticancer and arthritis treatment agents that interfere with DHODH by binding to the narrow region in the hydrophobic tunnel motif of the enzyme that leads to the flavin mononucleotide-ubiquinone redox site (25).